News Tagged ‘cardiovascular event’

GSK pays out more money to settle lawsuits against deadly diabetes drug

GlaxoSmithKline () has agreed to pay more than $250 million to resolve about 5,500 claims that its type 2 Avandia () caused heart attacks and strokes in patients who used the drug. The payout will help avoid the first trial over claims the pharmaceutical giant allowed the drug to be marketed despite reports that the drug was potentially deadly.

Read the rest of this entry »

FDA panel to decide fate of diabetes drug Avandia

The fate of the Avandia will likely be decided soon by an expert panel that has spent the past two days reviewing evidence that linked the drug to serious cardiovascular events and whether its developer and manufacturer, GlaxoSmithKline (), influenced the results of a study asserting the safety of Avandia.

Read the rest of this entry »